JNJ-80038114

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-80038114, covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer [Phase 1]